Public Health Agency of Canada

Laboratory testing found that Zentox Pure Air Technology was able to inactivate and remove all airborne organism types tested, including spores, mycobacterium, and viral species.

Werner Bischoff, MD, Ph.D., Director of Hospital Epidemiology is conducting a series of clinical trials on the Zentox Pure Air System. His conclusion after the first trial was that “use of the Zentox Pure Air instrument in an ED setting leads to a significant reduction of the airborne bacterial load. Applications of this new technology promise to reduce the pathogen load, reduce exposure, and provide a safe environment for patient care.”